Robert Metcalf

2.4k citations

34 papers · 790 indexed · 1 hit paper · h-index 11

Impact in

Cancer Research top 10%
- Cancer Genomics and Diagnostics
Oncology top 5%
- Cancer Cells and Metastasis
- Ear and Head Tumors

Papers in

Otorhinolaryngology 8
- Head and Neck Cancer Studies 8
Oncology 17
- Ear and Head Tumors 5
- Cancer Immunotherapy and Biomarkers 4

Co-authors: Fiona Blackhall Matthew Krebs Caroline Dive Ged Brady Louise Carter Howard D. Strickler Franco Bertoni Giancarlo Pizza
Journals: Annals of Oncology (7 papers)Journal of Clinical Oncology (6 papers)Cancer (3 papers)Oral Oncology (3 papers)Cancers (3 papers)
Partner nations: United Kingdom United States Canada

In The Last Decade

Robert Metcalf

29 papers receiving 774 citations

Hit Papers

align trajectories log scale

Molecular analysis of circulating tumour cells—biology and biomarkers 2014 · 490 citations

Peers

Countries citing papers authored by Robert Metcalf

Since Specialization

Citations

This map shows the geographic impact of Robert Metcalf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Metcalf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Metcalf more than expected).

Fields of papers citing papers by Robert Metcalf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Metcalf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Metcalf. The network helps show where Robert Metcalf may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert Metcalf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Metcalf Line = papers co-authored together Robert Metcalf links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluation of Clinical Parameters Associated with Response and Resistance to Cemiplimab in Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma: A Multi-Institutional Retrospective Cohort Study Current Oncology ·Alexandra Neagu, Clésio Rodrigues da Silva Júnior, T. YOSHIDA, Shyamaladevi Babu, Oliver Donnelly, Harriet S. Walter, Guy Faust, 夏雨, 易茗, Robert Metcalf	2025	0
2	The Clinical Utilisation and Duration of Treatment with HER2-Directed Therapies in HER2-Positive Recurrent or Metastatic Salivary Gland Cancers Current Oncology ·Alexandra Neagu, Clara Alice Gentil Daher, Clésio Rodrigues da Silva Júnior, Patrik Roos, Guy Betts, Kevin J. Harrington, Robert Metcalf	2024	0
3	904P Analysis of TP63 immunohistochemistry scores (IHC) by primary site and between primary and metastatic tumours in adenoid cystic carcinoma (ACC) Annals of Oncology ·Bjamsholt, Guy Betts, Alexandra Neagu, Antanas Ronis, Laura Feeney, Clésio Rodrigues da Silva Júnior, E. Jenny Heathcote, Kevin J. Harrington, Robert Metcalf	2024	0
4	Association of follow-up imaging frequency with temporal incidence and patterns of distant failure following (chemo) radiotherapy for HPV related oropharyngeal cancer Oral Oncology ·Eric Petersen, E Agresti, Pengshan, Kathryn Gottlieb, Erika Rodhotul Ainiyah, Arkadiusz Mula, Gareth Price, Robert Metcalf, Kate Garcez, Christopher D. Hughes, Saian Protasov, David Thomson, James Price, Juan Cachinero Zagalaz, Andrew McPartlin	2023	1
5	Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck Cancers ·Maria J. G. De-Castro, Bryan Bennett, Hristina Bachvarova, Grant D. Stewart, Ana Medina, Petr Szturz, Gabriel Feresin Pantalião, Clara Castro, E. Gemmen, Ashley Lau, Senne Vleminckx, Eric Winquist, Virginia Arrazubi, Desirée Hao, Audrey Cook, Joaquina Martínez-Galán, 里沙峠岡, Elizabeth Garner, David Gutiérrez Abad, Robert Metcalf	2023	2
6	854O INTERLINK-1: Phase III study of cetuximab (CTX) ± monalizumab (M) in participants (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) with disease progression on/after platinum chemotherapy (CT) and previously treated with an immune checkpoint inhibitor (ICI) Annals of Oncology ·Jérôme Fayette, Lisa Licitra, Kevin J. Harrington, Robert I. Haddad, Lillian L. Siu, Yi‐Chun Liu, Makoto Tahara, J-P. Machiels, Danny Rischin, Tanguy Y. Seiwert, Robert L. Ferris, Ulrich Keilholz, Amanda Psyrri, Bhumsuk Keam, Paolo Bossi, Robert Metcalf, Oscar K. Serrano, Paramjit Kaur, Makris Dimitris, Roger B. Cohen	2023	23
7	Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation Oral Oncology ·Laura Feeney, H. Bulantová, Helen Adderley, Clésio Rodrigues da Silva Júnior, David Morgan, Russell G. Walker, Rami Rauch, Patricia Graham, Joel Kaye, Kevin J. Harrington, Robert Metcalf	2022	19
8	Results of ACCURACY: A phase 2 trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notch ^mut ). Journal of Clinical Oncology ·Renata Ferrarotto, Robert Metcalf, Cristina P. Rodriguez, Jameel Muzaffar, Caroline Even, Cesar A. Perez, Carla M.L. van Herpen, Marc Oliva, Bing Xia, Daniel W. Bowles, Fordham Ingrid, Eric Winquist, Lori J. Wirth, Desirée Hao, Hyunseok Kang, Sébastien J. Hotte, Salomon M. Stemmer, Ranee Mehra, Francis P. Worden, Alan L. Ho	2022	14
9	Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer Cancers ·Clésio Rodrigues da Silva Júnior, Laura Feeney, H. Bulantová, Helen Adderley, J. J Jankowski, Guy Betts, George J. Burghel, Kevin J. Harrington, Robert Metcalf	2022	9
10	Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic Carcinoma Cancers ·Laura Feeney, Juan Cachinero Zagalaz, Matthew Beasley, Oliver Donnelly, Anthony Kong, R. Molerón, S. FUKABORI, Martin Rolles, Paul Sanghera, Zhaochao Han, William Wyman, Harriet S. Walter, Richard Webster, Robert Metcalf	2021	14
11	904P ACCURACY: A phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut): Results of 6-mg cohort Annals of Oncology ·Alan L. Ho, Daniel W. Bowles, Caroline Even, Desirée Hao, Hyunseok Kang, Robert Metcalf, Jameel Muzaffar, Marc Oliva, Cesar A. Perez, Aron Popovtzer, Cristina P. Rodriguez, Salomon M. Stemmer, Carla M. van Herpen, Eric Winquist, Lori J. Wirth, Francis P. Worden, Bing Xia, Gary Gordon, Renata Ferrarotto	2021	6
12	Appraising the Costs of Genomic Testing for Histology-Independent Technologies: An Illustrative Example for NTRK Fusions Value in Health ·Ludmila G. Kovnatskaya, Peter J. Murphy, Sofia Dias, Lindsay Claxton, Matthew Walton, Robert Metcalf, Hélene Schlecht, Christian H. Ottensmeier, Kouzou Shigemasa, Robert Hodgson	2021	4
13	919MO ACCURACY a phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut) Annals of Oncology ·Renata Ferrarotto, Lori J. Wirth, Jameel Muzaffar, Cristina P. Rodriguez, Bing Xia, Cesar A. Perez, Daniel W. Bowles, Eric Winquist, Sébastien J. Hotte, Robert Metcalf, Caroline Even, Gary Gordon, Alice Y. Ho	2020	17
14	922P EACH: A phase II study evaluating the safety and anti-tumour activity of avelumab and cetuximab in recurrent/metastatic squamous cell carcinomas Annals of Oncology ·Martin Förster, Robert Metcalf, Joseph J. Sacco, Anthony Kong, Graham Wheeler, Sharon Forsyth, Satiyo Komaki, Becca Milman, Renaud Avez, Helen L. Lowe, Victoria J. Spanswick, Leah Ensell, Pawan Bhati, Alson Pang	2020	5
15	Tipifarnib in recurrent, metastatic HRAS‐mutant salivary gland cancer Cancer ·Mykhailo Dubok, Jeffrey P. Guenette, Nicole G. Chau, Cyrus Sayehli, Christian Wilhelm, Robert Metcalf, Deborah Jean Lee Wong, Marcia S. Brose, Mohammad Razaq, Elísabeth Pérez-Ruiz, Ezra E.W. Cohen, Rahul Aggarwal, Catherine Scholz, Antonio Gualberto, Alan L. Ho	2020	37
16	Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer Clinical Oncology ·Kevin J. Harrington, Shreerang Bhide, Martin Förster, J. Good, Devy Yuliantari, Anthony Kong, Alan Melcher, Robert Metcalf, Pablo Nenclares, Kate Newbold, Christopher M. Nutting, Robin Prestwich, Joseph J. Sacco, Siti Farhana Hisham, Kee H. Wong	2020	1
17	The application of liquid biopsies in metastatic salivary gland cancer to identify candidate therapeutic targets Annals of Oncology ·Robert Metcalf, Sumitra Mohan, Said Hilton, Jackie Pierce, John M. Hudson, Guy Betts, Anshuman Chaturvedi, Jarrod J. Homer, Hui Sun Leong, Pietá Schofield, Dominic G. Rothwell, Gerard Brady, Caroline Dive	2017	2
18	Characterisation and risk assessment of venous thromboembolism in gastrointestinal cancers World Journal of Gastrointestinal Oncology ·Robert Metcalf, Erin. Loch, W. Radecki, Andrew N. Simmons, Clare Hodgson, Jian Li, Wasat Mansoor, Jurjees Hasan	2017	13
19	Molecular analysis of circulating tumour cells—biology and biomarkers Nature Reviews Clinical Oncology ·Matthew Krebs, Robert Metcalf, Louise Carter, Ged Brady, Fiona Blackhall, Caroline Dive Hit paper breakdown →	2014	490
20	Clinical Utility of Circulating Tumour Cell Detection in Non-Small-Cell Lung Cancer Current Treatment Options in Oncology ·Alberto Fusi, Robert Metcalf, Matthew Krebs, Caroline Dive, Fiona Blackhall	2013	18

About Robert Metcalf

Robert Metcalf is a scholar working on Otorhinolaryngology, Oncology, Internal Medicine, Surgery and Oral Surgery, having authored 34 papers that have together received 790 indexed citations. Recurring topics across this work include Salivary Gland Tumors Diagnosis and Treatment (17 papers), Head and Neck Cancer Studies (8 papers), Ear and Head Tumors (5 papers), Hedgehog Signaling Pathway Studies (4 papers), TGF-β signaling in diseases (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Colorectal and Anal Carcinomas (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Cancer Research (296 citations), Oncology (469 citations), Otorhinolaryngology (34 citations), Pulmonary and Respiratory Medicine (199 citations) and Oral Surgery (41 citations). Robert Metcalf has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Fiona Blackhall, Matthew Krebs, Caroline Dive, Ged Brady, Louise Carter, Howard D. Strickler, Franco Bertoni, Giancarlo Pizza, Raphael P. Viscidi and Weimin Qu. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer, Oral Oncology and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact